Ingalls & Snyder’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Ingalls & Snyder's EW Position: Q3 2026 in Review
Ingalls & Snyder increased its Edwards Lifesciences (EW) stake by 0.21% in Q3 2026, buying an estimated $711 and bringing the position to 3,758 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #349.
Ingalls & Snyder first reported a position in EW in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.01M in Q2 2023. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Ingalls & Snyder held 3,758 shares of Edwards Lifesciences worth $324K as of Q3 2026.
- Ingalls & Snyder bought 8 Edwards Lifesciences shares in Q3 2026, an estimated $711.
- Edwards Lifesciences made up 0.01% of Ingalls & Snyder's portfolio in Q3 2026, its #349 holding.
- Ingalls & Snyder first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 14 quarters since.
- Ingalls & Snyder's Edwards Lifesciences position peaked at $1.01M in Q2 2023.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.